UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Azenta, Inc. (NASDAQ:AZTA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 6.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 170,845 shares of the company's stock after purchasing an additional 9,969 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.37% of Azenta worth $8,542,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Picton Mahoney Asset Management boosted its holdings in shares of Azenta by 305.7% in the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after purchasing an additional 532 shares in the last quarter. Headlands Technologies LLC bought a new position in Azenta during the fourth quarter valued at $40,000. Covestor Ltd grew its holdings in Azenta by 64.2% during the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after acquiring an additional 799 shares in the last quarter. KBC Group NV lifted its position in shares of Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares during the last quarter. Finally, Quarry LP acquired a new position in Azenta in the 4th quarter worth approximately $110,000. Hedge funds and other institutional investors own 99.08% of the company's stock.

Azenta Stock Up 0.9%

Shares of NASDAQ:AZTA traded up $0.26 during trading on Wednesday, hitting $28.62. 556,026 shares of the company were exchanged, compared to its average volume of 699,450. The business's 50 day moving average is $27.56 and its 200-day moving average is $40.06. Azenta, Inc. has a 1-year low of $23.91 and a 1-year high of $63.58. The company has a market capitalization of $1.31 billion, a P/E ratio of -9.60 and a beta of 1.64.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. The business's revenue was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.06 earnings per share. As a group, sell-side analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AZTA. Evercore ISI boosted their price objective on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. TD Cowen upgraded Azenta to a "hold" rating in a research note on Thursday, February 27th. Finally, Needham & Company LLC reduced their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.